Lauren R. Klein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lauren R. Klein has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Brian E. Driver
A Department of Emergency Medicine , Hennepin County Medical Center , Minneapolis , MN , USA
5 shared publications- Jon B. Cole
Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN, USA
5 shared publications Marc L. Martel
Department of Emergency Medicine, Hennepin County Medical Center
5 shared publicationsJames R. Miner
A Department of Emergency Medicine , Hennepin County Medical Center , Minneapolis , MN , USA
3 shared publicationsErik Fagerstrom
A Department of Emergency Medicine , Hennepin County Medical Center , Minneapolis , MN , USA
2 shared publicationsAaron Robinson
Department of Emergency Medicine; Hennepin County Medical Center; Minneapolis MN
1 shared publication
Latest Publications
- 5 January 2021
- Published by Springer Nature
- p. 291-298
Mental Health Considerations After Sexual Assault
- 5 January 2021
- Published by Springer Nature
- p. 291-298
Mental Health Considerations After Sexual Assault
- 5 January 2021
- Published by Springer Nature
- p. 237-247
Agitation in the Emergency Department
- 4 February 2019
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 57 (8) , 697-702
An open-label randomized trial of intramuscular olanzapine versus oral clonidine for symptomatic treatment of opioid withdrawal in the emergency department*
Background: Patients with opioid withdrawal often present to the Emergency Department (ED), but many EDs do not have the infrastructure in place to initiate treatment with opioid agonists (methadone or buprenorphine). Therefore, ED management often entails symptomatic control. The purpose of this study was to compare olanzapine to clonidine for the treatment of opioid withdrawal symptoms. Methods: This was a prospective, randomized clinical trial comparing 10 mg of IM olanzapine to 0.3 mg of oral clonidine for symptoms of opioid withdrawal. Adult (18 years and older) ED patients reporting a history of opioid use and symptoms consistent with withdrawal were eligible. Patients were excluded if they had already received treatment during the ED encounter, were pregnant, incarcerated, or unable to provide consent. Patients were randomized 1:1 to receive olanzapine or clonidine for their initial treatment. A baseline Clinical Opiate Withdrawal Scale (COWS) score was calculated. After 30 min, the patient could receive any additional treatment at the ED physician’s discretion. The primary outcome was need for additional medication (rescue) within 1 h of study medication administration. Secondary outcomes included change in COWS score and adverse reactions. Results: We enrolled 63 patients (33 olanzapine, 30 clonidine). Demographic characteristics were similar for both groups (median age 45, range 21–67, 54% male) as well as baseline COWS score (median score 11). The median time since last opiate use was 48 h for both groups (range 4–116). Rescue was given within 1 h for olanzapine for 9 (27%) patients and for clonidine in 19 (63%) patients (difference 36%, 95% CI 13–59%). Decrease in COWS score at 1 h was 8.3 for olanzapine and 5.1 for clonidine (difference 3.2, 95% CI 0.3–6). Adverse events were uncommon: akathisia (1, olanzapine), hypotension (2, clonidine), respiratory depression (0). Conclusions: Treatment of opioid withdrawal symptoms with 10 mg of IM olanzapine results in a lower incidence of rescue medication administration and improved symptoms (COWS score) compared to 0.3 mg of oral clonidine.
- 4 February 2019
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 57 (8) , 697-702
An open-label randomized trial of intramuscular olanzapine versus oral clonidine for symptomatic treatment of opioid withdrawal in the emergency department*
Background: Patients with opioid withdrawal often present to the Emergency Department (ED), but many EDs do not have the infrastructure in place to initiate treatment with opioid agonists (methadone or buprenorphine). Therefore, ED management often entails symptomatic control. The purpose of this study was to compare olanzapine to clonidine for the treatment of opioid withdrawal symptoms. Methods: This was a prospective, randomized clinical trial comparing 10 mg of IM olanzapine to 0.3 mg of oral clonidine for symptoms of opioid withdrawal. Adult (18 years and older) ED patients reporting a history of opioid use and symptoms consistent with withdrawal were eligible. Patients were excluded if they had already received treatment during the ED encounter, were pregnant, incarcerated, or unable to provide consent. Patients were randomized 1:1 to receive olanzapine or clonidine for their initial treatment. A baseline Clinical Opiate Withdrawal Scale (COWS) score was calculated. After 30 min, the patient could receive any additional treatment at the ED physician’s discretion. The primary outcome was need for additional medication (rescue) within 1 h of study medication administration. Secondary outcomes included change in COWS score and adverse reactions. Results: We enrolled 63 patients (33 olanzapine, 30 clonidine). Demographic characteristics were similar for both groups (median age 45, range 21–67, 54% male) as well as baseline COWS score (median score 11). The median time since last opiate use was 48 h for both groups (range 4–116). Rescue was given within 1 h for olanzapine for 9 (27%) patients and for clonidine in 19 (63%) patients (difference 36%, 95% CI 13–59%). Decrease in COWS score at 1 h was 8.3 for olanzapine and 5.1 for clonidine (difference 3.2, 95% CI 0.3–6). Adverse events were uncommon: akathisia (1, olanzapine), hypotension (2, clonidine), respiratory depression (0). Conclusions: Treatment of opioid withdrawal symptoms with 10 mg of IM olanzapine results in a lower incidence of rescue medication administration and improved symptoms (COWS score) compared to 0.3 mg of oral clonidine.
- 1 October 2018
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 72 (4) , 374-385
Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department
- 1 October 2018
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 72 (4) , 374-385
Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation in the Emergency Department
- 1 July 2018
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (7) , 1209-1214
Emergency department length of stay for ethanol intoxication encounters
- 1 July 2018
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (7) , 1209-1214
Emergency department length of stay for ethanol intoxication encounters
- Open Access
- 5 March 2018
- Published by Western Journal of Emergency Medicine in Western Journal of Emergency Medicine
- Vol. 19 (2) , 398-402
Emergency Department Frequent Users for Acute Alcohol Intoxication
Introduction: A subset of frequent users of emergency services are those who use the emergency department (ED) for acute alcohol intoxication. This population and their ED encounters have not been previously described. Methods: This was a retrospective, observational, cohort study of patients presenting to the ED for acute alcohol intoxication between 2012 and 2016. We collected all data from the electronic medical record. Frequent users for alcohol intoxication were defined as those with greater than 20 visits for acute intoxication without additional medical chief complaints in the previous 12 months. We used descriptive statistics to evaluate characteristics of frequent users for alcohol intoxication, as well as their ED encounters. Results: We identified 32,121 patient encounters. Of those, 325 patients were defined as frequent users for alcohol intoxication, comprising 11,370 of the encounters during the study period. The median maximum number of encounters per person for alcohol intoxication in a one-year period was 47 encounters (range 20 to 169). Frequent users were older (47 years vs. 39 years), and more commonly male (86% vs. 71%). Frequent users for alcohol intoxication had higher rates of medical and psychiatric comorbidities including liver disease, chronic kidney disease, ischemic vascular disease, dementia, chronic obstructive pulmonary disease, history of traumatic brain injury, schizophrenia, and bipolar disorder. Conclusion: In this study, we identified a group of ED frequent users who use the ED for acute alcohol intoxication. This population had higher rates of medical and psychiatric comorbidities compared to non-frequent users.
- 5 March 2018
- Published by Western Journal of Emergency Medicine in Western Journal of Emergency Medicine
- Vol. 19 (2) , 398-402
Open AccessEmergency Department Frequent Users for Acute Alcohol Intoxication
Introduction: A subset of frequent users of emergency services are those who use the emergency department (ED) for acute alcohol intoxication. This population and their ED encounters have not been previously described. Methods: This was a retrospective, observational, cohort study of patients presenting to the ED for acute alcohol intoxication between 2012 and 2016. We collected all data from the electronic medical record. Frequent users for alcohol intoxication were defined as those with greater than 20 visits for acute intoxication without additional medical chief complaints in the previous 12 months. We used descriptive statistics to evaluate characteristics of frequent users for alcohol intoxication, as well as their ED encounters. Results: We identified 32,121 patient encounters. Of those, 325 patients were defined as frequent users for alcohol intoxication, comprising 11,370 of the encounters during the study period. The median maximum number of encounters per person for alcohol intoxication in a one-year period was 47 encounters (range 20 to 169). Frequent users were older (47 years vs. 39 years), and more commonly male (86% vs. 71%). Frequent users for alcohol intoxication had higher rates of medical and psychiatric comorbidities including liver disease, chronic kidney disease, ischemic vascular disease, dementia, chronic obstructive pulmonary disease, history of traumatic brain injury, schizophrenia, and bipolar disorder. Conclusion: In this study, we identified a group of ED frequent users who use the ED for acute alcohol intoxication. This population had higher rates of medical and psychiatric comorbidities compared to non-frequent users.
- 1 March 2018
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 71 (3) , 279-288
Unsuspected Critical Illness Among Emergency Department Patients Presenting for Acute Alcohol Intoxication
- 1 March 2018
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 71 (3) , 279-288
Unsuspected Critical Illness Among Emergency Department Patients Presenting for Acute Alcohol Intoxication
- 1 November 2017
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 35 (11) , 1624-1629
Endovascular rewarming in the emergency department for moderate to severe accidental hypothermia
- 1 November 2017
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 35 (11) , 1624-1629
Endovascular rewarming in the emergency department for moderate to severe accidental hypothermia
- 4 October 2017
- Published by Wiley in Academic Emergency Medicine
- Vol. 24 (11) , 1405-1409
Identifying Emergency Department Patients at Low Risk for a Variceal Source of Upper Gastrointestinal Hemorrhage
- 4 October 2017
- Published by Wiley in Academic Emergency Medicine
- Vol. 24 (11) , 1405-1409
Identifying Emergency Department Patients at Low Risk for a Variceal Source of Upper Gastrointestinal Hemorrhage
- 17 February 2016
- Published by Wiley in Academic Emergency Medicine
- Vol. 23 (3) , e2
Technique for Exchanging the King Laryngeal Tube for an Endotracheal Tube
- 17 February 2016
- Published by Wiley in Academic Emergency Medicine
- Vol. 23 (3) , e2
Technique for Exchanging the King Laryngeal Tube for an Endotracheal Tube